One study in ER+ BC demonstrated how high expression of Hallmark E2F targets is associated with aggressiveness and MKI67‐expression [38], thus, reduction of such signatures in tumors with better response to treatment aligns with the observed reduction in proliferation/growth in the combination group. This evidence concerns the gene MKI67 and breast cancer.